Overview

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational, 10-year, prospective cohort study is to assess the potential safety concerns of long-term exposure to EGRIFTA® in HIV-infected subjects with abdominal lipohypertrophy compared with a similar group of subjects not exposed to EGRIFTA®.
Details
Lead Sponsor:
Theratechnologies
Treatments:
Growth Hormone-Releasing Hormone
Tesamorelin